Simplex Trading, LLC Bria Cell Therapeutics Corp. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$5.72 - $7.58 $220,088 - $291,655	38,477 Added 3685.54%	39,521 $253,000
Q1 2023 Apr 27, 2023	SELL	$4.59 - $7.99 $127,840 - $222,537	-27,852 Reduced 96.39%	1,044 $7,000
Q4 2022 Feb 02, 2023	BUY	$4.28 - $6.73 $49,545 - $77,906	11,576 Added 66.84%	28,896 $126,000
Q3 2022 Nov 04, 2022	BUY	$3.0 - $8.31 $51,960 - $143,929	17,320 New	17,320 $97,000
Q2 2022 Aug 03, 2022	SELL	$4.28 - $11.9 $109,978 - $305,782	-25,696 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$5.91 - $10.14 $136,089 - $233,493	23,027 Added 862.76%	25,696 $260,000
Q4 2021 Feb 23, 2022	BUY	$7.1 - $10.61 $18,949 - $28,318	2,669 New	2,669 $22,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $13.7M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.